Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Changes of Keratometric Value and Ocular Aberration After Treatment of Meibomian Gland Dysfunction

NCT01692665 is registered in ClinicalTrials.gov with Yonsei University as lead sponsor.

NCT NCT01692665
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01692665 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Changes of Keratometric Value and Ocular Aberration After Treatment of Meibomian Gland Dysfunction
Lead sponsor
Yonsei University
Phase
Observational
Overall status
Withdrawn
Start date
November 30, 2012
Completion date
December 31, 2012
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

moderate and severe meibomiang gland dysfunction (stage 3 or stage 4 meibomiang gland dysfunction)